Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Urinary Bladder Neoplasms 2Glioblastoma 2Stomach Neoplasms 1Solitary Pulmonary Nodule 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Pulmonary Nodules 1Medication Adherence 1Margins of Excision 1Lymphoma, Follicular 1Lung Neoplasms 1Glioma 1Esophageal Neoplasms 1Early-stage Peripheral Non-small Cell Lung Cancer 1Dementia 1Cognitive Dysfunction 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Brain Neoplasms 1Alzheimer Disease 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Drug Delivery Systems × 1 year × Clear all
NCT07487844 2026-03-23

Pulsed Electric Field Ablation for Metastatic Breast Cancer

University of California, San Francisco

Phase NA Not yet recruiting
20 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡